These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22666228)

  • 1. The epigenetics of renal cell tumors: from biology to biomarkers.
    Henrique R; Luís AS; Jerónimo C
    Front Genet; 2012; 3():94. PubMed ID: 22666228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of epigenetics in kidney malignancies.
    la Rosa AH; Acker M; Swain S; Manoharan M
    Cent European J Urol; 2015; 68(2):157-64. PubMed ID: 26251734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
    Toiyama Y; Okugawa Y; Goel A
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and cell cycle regulation in cystogenesis.
    Li X
    Cell Signal; 2020 Apr; 68():109509. PubMed ID: 31874209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated chromatin remodeling in the pathobiology of brain tumors.
    Spyropoulou A; Piperi C; Adamopoulos C; Papavassiliou AG
    Neuromolecular Med; 2013 Mar; 15(1):1-24. PubMed ID: 23114751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics in renal cell cancer: mechanisms and clinical applications.
    Joosten SC; Smits KM; Aarts MJ; Melotte V; Koch A; Tjan-Heijnen VC; van Engeland M
    Nat Rev Urol; 2018 Jul; 15(7):430-451. PubMed ID: 29867106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights on chromatin modifiers and histone post-translational modifications in renal cell tumours.
    Vieira-Coimbra M; Henrique R; Jerónimo C
    Eur J Clin Invest; 2015 Jan; 45 Suppl 1():16-24. PubMed ID: 25524582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in kidney diseases.
    Ding H; Zhang L; Yang Q; Zhang X; Li X
    Adv Clin Chem; 2021; 104():233-297. PubMed ID: 34462056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer epigenetics: Moving forward.
    Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
    PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications in gastric cancer: Focus on DNA methylation.
    Ebrahimi V; Soleimanian A; Ebrahimi T; Azargun R; Yazdani P; Eyvazi S; Tarhriz V
    Gene; 2020 Jun; 742():144577. PubMed ID: 32171825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?
    Khan SA; Reddy D; Gupta S
    World J Biol Chem; 2015 Nov; 6(4):333-45. PubMed ID: 26629316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in cancer.
    Sharma S; Kelly TK; Jones PA
    Carcinogenesis; 2010 Jan; 31(1):27-36. PubMed ID: 19752007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Modifications in Head and Neck Cancer.
    Gaździcka J; Gołąbek K; Strzelczyk JK; Ostrowska Z
    Biochem Genet; 2020 Apr; 58(2):213-244. PubMed ID: 31712935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer epigenetics: above and beyond.
    Brait M; Sidransky D
    Toxicol Mech Methods; 2011 May; 21(4):275-88. PubMed ID: 21495866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Histone Onco- Modifications Using Plant-Derived Products.
    Illam SP; Kandiyil SP; Raghavamenon AC
    Curr Drug Targets; 2021; 22(11):1317-1331. PubMed ID: 33461463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.